Patents by Inventor Naveh TOV

Naveh TOV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10960062
    Abstract: The present invention disclosed methods for early intervention and prevention of the progression of pulmonary diseases, by administering alpha 1-antitrypsin (AAT) and particularly by administering AAT by inhalation.
    Type: Grant
    Filed: February 21, 2018
    Date of Patent: March 30, 2021
    Assignee: KAMADA LTD.
    Inventor: Naveh Tov
  • Publication number: 20210085765
    Abstract: Methods for pre-emptive prophylactic treatment of graft versus host disease (GvHD) are disclosed. Such methods comprise the administration of Alpha-1 Antitrypsin (AAT) for pre-emption of GvHD.
    Type: Application
    Filed: December 2, 2020
    Publication date: March 25, 2021
    Applicant: KAMADA LTD.
    Inventors: Naveh TOV, Michal STEIN
  • Publication number: 20210008183
    Abstract: The present invention disclosed methods for suppressing or preventing an immune response to a specific antigen in a subject, comprising administering to the subject, the specific antigen by an intravenous route followed by an inhalation route.
    Type: Application
    Filed: December 10, 2018
    Publication date: January 14, 2021
    Applicant: KAMADA LTD.
    Inventor: Naveh TOV
  • Publication number: 20200282031
    Abstract: The present invention discloses methods for preventing or reducing lung injury associated with lung transplantation in lung transplant recipients. The method of the invention comprises the administration of improved dosage regimen of Alpha-1 Antitrypsin (AAT) for prevention of acute and/or chronic refractory rejection in lung transplant patients.
    Type: Application
    Filed: October 29, 2018
    Publication date: September 10, 2020
    Applicant: KAMADA LTD.
    Inventor: Naveh TOV
  • Publication number: 20200046815
    Abstract: The present invention relates to the field of preservation of functional pancreatic islet (beta-cells) and treatment of diabetes, providing improved dosage regimen of AAT administration to Type 1 Diabetes Mellitus (T1DM) patients, particularly to newly diagnosed T1DM patients. The improved dose regiment is a multiple variable dosage regimen, comprising and induction phase and a treatment phase.
    Type: Application
    Filed: October 10, 2017
    Publication date: February 13, 2020
    Inventors: Pnina STRAUSS, Naveh TOV
  • Publication number: 20140350355
    Abstract: A method of monitoring a patient to identify a sleep breathing disorder, comprising: a) Collecting, using a handheld monitoring device, a plurality of respiratory sounds of a patient using one or more sensors which are connected to the handheld monitoring device. b) Recording environment noise during the sleep session and averaging the environment noise to set an average noise level. c) Calculating a dynamic threshold according to the average noise level. d) Deriving a plurality of amplitudes from the plurality of respiratory sounds according to the dynamic threshold. e) Identifying a sleep breathing disorder event by analyzing a pattern of the plurality of amplitudes.
    Type: Application
    Filed: May 27, 2014
    Publication date: November 27, 2014
    Applicant: P-Tech HM Ltd.
    Inventors: Ilan AISIC, Naveh TOV